ADC Therapeutics SA (ADCT) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed ADC Therapeutics SA (ADCT) over the past year, gaining 62.9% versus a loss of 65.0%. Over five years, WHWK leads with a -87.5% price change compared with -93.8% for ADCT. ADC Therapeutics SA is the larger company by market cap ($203.0 million vs $197.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | WHWK |
|---|---|---|
| Share price | $1.59 | $3.47 |
| Market cap | $202.99M | $197.82M |
| 1-day change | +11.97% | +1.76% |
| YTD return | -54.96% | +43.39% |
| 1-year return | -64.98% | +62.91% |
| 5-year return | -93.76% | -87.47% |
| EPS (TTM) | $-0.60 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $5.50 |
| 52-week low | $0.78 | $1.87 |
| Distance from 52-week high | -68.07% | -36.85% |
| Analyst consensus | none | buy |
| Avg. price target upside | +109.43% | +122.19% |
| Average volume | 1.43M | 367.72K |
| Shares outstanding | 127.67M | 57.01M |
| Employees | 188 | 32 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed ADCT by 127.9 percentage points over the past year.
- The two companies sit in different sectors: ADC Therapeutics SA in Health Care and Whitehawk Therapeutics in Healthcare.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Healthcare · Biotechnology · 32 employees
ADCT vs WHWK FAQ
Which is bigger, ADC Therapeutics SA or Whitehawk Therapeutics?
ADC Therapeutics SA (ADCT) is larger, with a market capitalization of $202.99M compared with $197.82M for Whitehawk Therapeutics (WHWK).
Which stock has performed better over the past year, ADCT or WHWK?
WHWK returned +62.91% over the past 12 months, compared with -64.98% for ADCT (price return, excluding dividends). Past performance does not predict future results.
Are ADC Therapeutics SA and Whitehawk Therapeutics in the same industry?
No. ADC Therapeutics SA is in the Health Care sector, while Whitehawk Therapeutics is in Healthcare.